Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey

References

• American Diabetes Association. Dyslipidemia management in adults with diabetes. Position statement & ADA statement. Diabetes Care. 2004;27(suppl):S68–71. doi:10.2337/diacare.27.2007.S68
   PubMedGoogle Scholar
• Kyung-Hyun C, Hye-Jeong P, Jae-Ryong K. Decrease in Serum HDL-C level is associated with elevation of blood pressure: correlation analysis from the korean national health and nutrition examination survey 2017. Int J Environ Res Public Health. 2020; 17: undefined.
   Google Scholar
• Tsuruya K, Yoshida H, Nagata M, et al. Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: A longitudinal study in a large Japanesepopulation. Am J Kidney Dis. 2015;66(6):972–983. doi:10.1053/j.ajkd.2015.05.011
   PubMedGoogle Scholar
• Rosenson RS, Davidson MH, Le NA, Burkle J, Pourfarzib R. Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy. Cardiovasc Drug Ther. 2015;29:41–50. doi:10.1007/s10557-014-6567-0
   PubMed Web of Science ®Google Scholar
• Kontush A, Chapman MJ. Antiatherogenic small, dense HDL – guardian angel of the arterial wall?. Nat Clin Pract Cardiovasc Med. 2006;3:144–153.
   PubMedGoogle Scholar
• Lincoff AM, Nicholls SJ, Riesmeyer JS, et al. Evacetrapib and cardiovascular outcomes in high-risk vascular disease. N Engl J Med. 2017;376:1933–1942. doi:10.1056/NEJMoa1609581
   PubMed Web of Science ®Google Scholar
• Benjamin B, Yan X, Hong X, Sumitra B, Ziyad -A-A. Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression. Kidney Int. 2016;89:886–896. doi:10.1016/j.kint.2015.12.034
   PubMedGoogle Scholar
• Hirata A, Okamura T, Sugiyama D, et al. The relationship between very high levels of serum high-density lipoprotein cholesterol and cause-specific mortality in a 20-year follow-up study of Japanese general population. J Atheroscler Thromb. 2016;23:800–809. doi:10.5551/jat.33449
   PubMed Web of Science ®Google Scholar
• Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38:2478–2486. doi:10.1093/eurheartj/ehx163
   PubMed Web of Science ®Google Scholar
• Hirata A, Sugiyama D, Watanabe M, et al. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: the EPOCH-JAPAN study. J Clin Lipidol. 2018;12:674–684.e5. doi:10.1016/j.jacl.2018.01.014
   PubMedGoogle Scholar
• Schunkert H, Konig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333–338. doi:10.1038/ng.784
   PubMed Web of Science ®Google Scholar
• Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707–713. doi:10.1038/nature09270
   PubMed Web of Science ®Google Scholar
• Vitali C, Khetarpal SA, Rader DJ. HDL cholesterol metabolism and the risk of CHD: new insights from human genetics. Curr Cardiol Rep. 2017;19:132. doi:10.1007/s11886-017-0940-0
   PubMed Web of Science ®Google Scholar
• Kajani S, Sean C, Fiona C, Gillicuddy M. Unravelling HDL-looking beyond the cholesterol surface to the quality within. Int J Mol Sci. 2018;19:1971–1999.
   PubMedGoogle Scholar
• Qaddoumi Mohammad G, Muath A, Hammad Maha M, et al. Investigating the role of myeloperoxidase and angiopoietin-like protein 6 in obesity and diabetes. Sci Rep. 2020;10(1):6170–6181. doi:10.1038/s41598-020-63149-7
   PubMedGoogle Scholar
• Ghazi L, Baker Jason V, Sharma S, et al. Role of inflammatory biomarkers in the prevalence and incidence of hypertension among hiv-positive participants in the START Trial. Am J Hypertension. 2020;33(1):43–52. doi:10.1093/ajh/hpz132
   PubMedGoogle Scholar
• Jianhua W, Naifeng G, Chen Xiaolan et al. Coexistence of micro-inflammatory and macrophage phenotype abnormalities in chronic kidney disease. Int J Clin Exp Pathol. 2020;13:317–323.
   PubMedGoogle Scholar
• World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, 2006[M]. Geneva: WHO Document Production Services, 2006.
   Google Scholar
• Chalmers J, MacMahon S, Mancia G, et al. WHO-ISH hypertension guidelines committee. 1999 world health organization–international society of hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151–183.
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100. doi:10.1111/j.1523-1755.2005.00365.x
   PubMed Web of Science ®Google Scholar
• Eknoyan G, Levin N. NKF-K/DOQI clinical practice guidelines: update 2000. Foreword. Am J Kidney Dis. 2001;37(1 Suppl):S5–S6. doi:10.1016/S0272-6386(01)70004-2
   PubMedGoogle Scholar
• Moriyama Y, Okamura T, Inazu A, et al. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev Med. 1998;27:659–667. doi:10.1006/pmed.1998.0340
   PubMed Web of Science ®Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523. doi:10.1001/jama.2017.7596
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Zhang L, et al. Status of hypertension in china: results from the china hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
   PubMed Web of Science ®Google Scholar
• Ene-Iordache B, Perico N, Bikbov B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307–e319. doi:10.1016/S2214-109X(16)00071-1
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6
   PubMed Web of Science ®Google Scholar
• Taal MW. Chronic kidnev disease: towards a Iisk-based approach. Clin Med. 2016;16(Suppl 6):s117–s120.
   PubMedGoogle Scholar
• Wang YL, Koh WP, Talaei M, Yuan JM, Pan A. Association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women. J Diab. 2017;9(7):689–698. doi:10.1111/1753-0407.12477
   PubMedGoogle Scholar
• Kunutsor SK, Kieneker LM, Bakker SJL, James RW, Dullaart RPF. The inverse association of HDL-cholesterol with future risk of hypertension is not modified by its antioxidant constituent, paraoxonase-1: the PREVEND prospective cohort study. Atherosclerosis. 2017;263:219–226. doi:10.1016/j.atherosclerosis.2017.06.353
   PubMedGoogle Scholar
• Ain QU, Asif N, Alam A, Gilani M, Noreen SW. Triglycerides-to-hdlc ratio as a marker of cardiac disease and vascular risk factors in adults. J Coll Physicians Surg Pak. 2019;29(11):1034–1037. doi:10.29271/jcpsp.2019.11.1034
   PubMedGoogle Scholar
• Camont L, Chapman MJ, Kontush A. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med. 2011;17:594–603. doi:10.1016/j.molmed.2011.05.013
   PubMed Web of Science ®Google Scholar
• Kontush A, Lhomme M, Chapman MJ. Unraveling the complexities of the HDL lipidome. J Lipid Res. 2013;54:2950–2963.
   PubMed Web of Science ®Google Scholar
• Kajani S, Curley S, McGillicudd. FC. Unravelling HDL-looking beyond the cholesterol surface to the quality within. Int J Mol Sci. 2018;19:1971. doi:10.3390/ijms19071971
   PubMedGoogle Scholar
• Wan Ahmad Wan NH, Sakri F, Mokhsin A, et al. Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation. PLoS One. 2015;10:e0116867. doi:10.1371/journal.pone.0116867
   PubMedGoogle Scholar
• Gillard BK, Lin HY, Massey JB, Pownall HJ. Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells. Biochim Biophy Acta. 2009;1791:1125–1132. doi:10.1016/j.bbalip.2009.07.004
   PubMed Web of Science ®Google Scholar